Bolt Biotherapeutics Management
Management criteria checks 3/4
Bolt Biotherapeutics' CEO is Randy Schatzman, appointed in Jul 2019, has a tenure of 4.75 years. total yearly compensation is $2.24M, comprised of 25.2% salary and 74.8% bonuses, including company stock and options. directly owns 0.034% of the company’s shares, worth $14.79K. The average tenure of the management team and the board of directors is 4 years and 3.3 years respectively.
Key information
Randy Schatzman
Chief executive officer
US$2.2m
Total compensation
| CEO salary percentage | 25.2% |
| CEO tenure | 4.8yrs |
| CEO ownership | 0.03% |
| Management average tenure | 4yrs |
| Board average tenure | 3.3yrs |
Recent management updates
Recent updates
We Think Bolt Biotherapeutics (NASDAQ:BOLT) Needs To Drive Business Growth Carefully
Mar 15
Is Bolt Biotherapeutics (NASDAQ:BOLT) In A Good Position To Deliver On Growth Plans?
May 13Is Bolt Biotherapeutics (NASDAQ:BOLT) In A Good Position To Deliver On Growth Plans?
Dec 01Bolt Biotherapeutics: A Promised Follow Up
Aug 26Bolt Biotherapeutics GAAP EPS of -$0.61 beats by $0.08, revenue of $1.39M beats by $0.89M
Aug 10We're Keeping An Eye On Bolt Biotherapeutics' (NASDAQ:BOLT) Cash Burn Rate
Jul 27We're Not Very Worried About Bolt Biotherapeutics' (NASDAQ:BOLT) Cash Burn Rate
Apr 12We Think Bolt Biotherapeutics (NASDAQ:BOLT) Can Afford To Drive Business Growth
Dec 03Bolt Biotherapeutics: Pioneering A New Class Of Immunotherapies
Aug 18We're Hopeful That Bolt Biotherapeutics (NASDAQ:BOLT) Will Use Its Cash Wisely
Aug 18CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -US$69m |
| Sep 30 2023 | n/a | n/a | -US$71m |
| Jun 30 2023 | n/a | n/a | -US$77m |
| Mar 31 2023 | n/a | n/a | -US$81m |
| Dec 31 2022 | US$2m | US$564k | -US$88m |
| Sep 30 2022 | n/a | n/a | -US$95m |
| Jun 30 2022 | n/a | n/a | -US$97m |
| Mar 31 2022 | n/a | n/a | -US$98m |
| Dec 31 2021 | US$6m | US$545k | -US$99m |
| Sep 30 2021 | n/a | n/a | -US$102m |
| Jun 30 2021 | n/a | n/a | -US$89m |
| Mar 31 2021 | n/a | n/a | -US$77m |
| Dec 31 2020 | US$2m | US$458k | -US$61m |
| Sep 30 2020 | n/a | n/a | -US$39m |
| Jun 30 2020 | n/a | n/a | -US$36m |
| Mar 31 2020 | n/a | n/a | -US$32m |
| Dec 31 2019 | US$2m | US$206k | -US$30m |
Compensation vs Market: Randy's total compensation ($USD2.24M) is above average for companies of similar size in the US market ($USD674.64K).
Compensation vs Earnings: Randy's compensation has been consistent with company performance over the past year.
CEO
Randy Schatzman (68 yo)
4.8yrs
Tenure
US$2,235,412
Compensation
Dr. Randall C. Schatzman, also known as Randy, Ph D., has been the Chief Executive Officer and Director at Bolt Biotherapeutics, Inc. since July 2019. Dr. Schatzman joined the Bolt Biotherapeutics, Inc. in...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 4.8yrs | US$2.24m | 0.034% $ 14.8k | |
| Founder & Independent Director | no data | US$129.24k | 3.2% $ 1.4m | |
| CFO & Secretary | 3.9yrs | US$1.06m | 0.095% $ 41.7k | |
| Chief Business Officer | 7.4yrs | US$968.77k | 0.023% $ 10.3k | |
| Chief Medical Officer | 4yrs | US$1.14m | 0.12% $ 53.6k | |
| VP & Head of Human Resources | 2.9yrs | no data | no data | |
| Senior Vice President of Pharmaceutical Operations | 1.8yrs | no data | no data |
4.0yrs
Average Tenure
66yo
Average Age
Experienced Management: BOLT's management team is considered experienced (4 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 4.8yrs | US$2.24m | 0.034% $ 14.8k | |
| Founder & Independent Director | 9.3yrs | US$129.24k | 3.2% $ 1.4m | |
| Independent Director | 3.3yrs | US$165.11k | 0.0032% $ 1.4k | |
| Independent Director | 6.8yrs | US$162.86k | 0.041% $ 17.9k | |
| Lead Independent Director | 3.3yrs | US$137.24k | 0% $ 0 | |
| Member of Scientific Advisory Board | 3.2yrs | no data | no data | |
| Independent Director | 7.6yrs | US$136.99k | 0% $ 0 | |
| Independent Director | 2.4yrs | US$168.65k | 0% $ 0 | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 2.4yrs | US$160.15k | 0% $ 0 | |
| Member of Scientific Advisory Board | no data | no data | no data |
3.3yrs
Average Tenure
64yo
Average Age
Experienced Board: BOLT's board of directors are considered experienced (3.3 years average tenure).